N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39257 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O6S |
| Mol.Wt. | 580.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39258 |
| CAS No | 349125-14-0 |
| Mol.F. | C12H8Cl2N4O2 |
| Mol.Wt. | 311.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39259 |
| CAS No | NA |
| Mol.F. | C24H27ClN7O4S |
| Mol.Wt. | 545g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39260 |
| CAS No | 1392745-22-0 |
| Mol.F. | C14H25NO5 |
| Mol.Wt. | 287.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39261 |
| CAS No | 1541782-99-3 |
| Mol.F. | C9H12N2O2S |
| Mol.Wt. | 212.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39262 |
| CAS No | NA |
| Mol.F. | C25H32ClN7O4S |
| Mol.Wt. | 562.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39263 |
| CAS No | NA |
| Mol.F. | C24H28ClN7O4S |
| Mol.Wt. | 546g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39264 |
| CAS No | NA |
| Mol.F. | C24H28ClN7O4S |
| Mol.Wt. | 546g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39265 |
| CAS No | NA |
| Mol.F. | C24H29ClN7O4S |
| Mol.Wt. | 547.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39266 |
| CAS No | 165948-21-0 |
| Mol.F. | C12H16N2O4S |
| Mol.Wt. | 284.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39267 |
| CAS No | 92333-99-8 |
| Mol.F. | C7H10N2OS |
| Mol.Wt. | 170.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39268 |
| CAS No | 365997-33-7 |
| Mol.F. | C14H25NO5 |
| Mol.Wt. | 287.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39269 |
| CAS No | 1150542-43-0 |
| Mol.F. | C12H11ClN2 |
| Mol.Wt. | 218.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39270 |
| CAS No | 123536-66-3 |
| Mol.F. | C7H9IO2 |
| Mol.Wt. | 252.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39271 |
| CAS No | 1392745-70-8 |
| Mol.F. | C14H25NO5 |
| Mol.Wt. | 287.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39272 |
| CAS No | NA |
| Mol.F. | C35H47ClN10O7S |
| Mol.Wt. | 787.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |